Skip to main content
Erschienen in: World Journal of Surgery 9/2019

13.05.2019 | Original Scientific Report

A Population-Based Study of Incidence, Presentation, Management and Outcome of Primary Thromboembolic Ischemia in the Upper Extremity

verfasst von: Jørgen B. Vennesland, Kjetil Søreide, Jan Terje Kvaløy, Andreas Reite, Morten Vetrhus

Erschienen in: World Journal of Surgery | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate the epidemiology of acute upper limb thromboembolism in a well-defined Norwegian population.

Methods

This study was a retrospective, single-center, observational population-based cohort study of acute upper limb thromboembolism. The study included all patients from the hospital’s primary catchment area from January 2000 to December 2015. Age- and gender-adjusted incidence rates were calculated using population demographics from Statistics Norway.

Results

A total of 54 patients were identified, of which 49 were included in the analyses: 27 (55%) females (median age 83 years, range 40–96) and 22 (45%) males (median age 70 years, range 42–95) (P = .053). The adjusted incidence rate for the period was 1.6 patients per 100,000 inhabitants per year (95% confidence interval 1.2–2.2) and did not change significantly during the period studied. Atrial fibrillation was detected by electrocardiography in 30 (61%) patients; in this group, 10 patients were on warfarin but only two had an international normalized ratio > 1.9 and the remaining 20 were not anticoagulated. Altogether, 38 (78%) patients underwent surgery, 1 (2%) was treated with thrombolysis, and the remaining patients were treated conservatively; no amputations were performed. Four patients (8%) died within 30 days, and 12 of the surviving 45 patients (27%) had recurrent thromboembolism.

Conclusion

The incidence rate was stable during the study period. Patients with upper limb thromboembolism due to atrial fibrillation were inadequately anticoagulated. One in four patients experienced a recurrent thromboembolic event. Lifelong anticoagulation should be considered in all patients with upper limb thromboembolism.
Literatur
1.
2.
Zurück zum Zitat Andersen LV, Lip GY, Lindholt JS et al (2013) Upper limb arterial thromboembolism: a systematic review on incidence, risk factors, and prognosis, including a meta-analysis of risk-modifying drugs. JTH 11:836–844PubMed Andersen LV, Lip GY, Lindholt JS et al (2013) Upper limb arterial thromboembolism: a systematic review on incidence, risk factors, and prognosis, including a meta-analysis of risk-modifying drugs. JTH 11:836–844PubMed
3.
Zurück zum Zitat Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857–867CrossRefPubMed Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857–867CrossRefPubMed
4.
Zurück zum Zitat Stonebridge PA, Clason AE, Duncan AJ et al (1989) Acute ischaemia of the upper limb compared with acute lower limb ischaemia; a 5-year review. Br J Surg 76:515–516CrossRefPubMed Stonebridge PA, Clason AE, Duncan AJ et al (1989) Acute ischaemia of the upper limb compared with acute lower limb ischaemia; a 5-year review. Br J Surg 76:515–516CrossRefPubMed
5.
Zurück zum Zitat Skeik N, Soo-Hoo SS, Porten BR et al (2015) Arterial embolisms and thrombosis in upper extremity ischemia. Vasc Endovasc Surg 49:100–109CrossRef Skeik N, Soo-Hoo SS, Porten BR et al (2015) Arterial embolisms and thrombosis in upper extremity ischemia. Vasc Endovasc Surg 49:100–109CrossRef
6.
Zurück zum Zitat Conte MS, Pomposelli FB, Clair DG et al (2015) Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg 61:2s–41sCrossRefPubMed Conte MS, Pomposelli FB, Clair DG et al (2015) Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg 61:2s–41sCrossRefPubMed
7.
Zurück zum Zitat Aboyans V, Ricco JB, Bartelink MEL et al (2018) Editor’s choice—2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg 55:305–368CrossRefPubMed Aboyans V, Ricco JB, Bartelink MEL et al (2018) Editor’s choice—2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg 55:305–368CrossRefPubMed
8.
Zurück zum Zitat Andersen LV, Mortensen LS, Lindholt JS et al (2010) Upper-limb thrombo-embolectomy: national cohort study in Denmark. Eur J Vasc Endovasc Surg 40:628–634CrossRefPubMed Andersen LV, Mortensen LS, Lindholt JS et al (2010) Upper-limb thrombo-embolectomy: national cohort study in Denmark. Eur J Vasc Endovasc Surg 40:628–634CrossRefPubMed
9.
Zurück zum Zitat Dryjski M, Swedenborg J (1984) Acute ischemia of the extremities in a metropolitan area during one year. J Cardiovasc Surg 25:518–522 Dryjski M, Swedenborg J (1984) Acute ischemia of the extremities in a metropolitan area during one year. J Cardiovasc Surg 25:518–522
10.
Zurück zum Zitat Pentti J, Salenius JP, Kuukasjarvi P et al (1995) Outcome of surgical treatment in acute upper limb ischaemia. Ann Chir Gynaecol 84:25–28PubMed Pentti J, Salenius JP, Kuukasjarvi P et al (1995) Outcome of surgical treatment in acute upper limb ischaemia. Ann Chir Gynaecol 84:25–28PubMed
11.
Zurück zum Zitat Andrade J, Khairy P, Dobrev D et al (2014) The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res 114:1453–1468CrossRefPubMed Andrade J, Khairy P, Dobrev D et al (2014) The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res 114:1453–1468CrossRefPubMed
12.
Zurück zum Zitat von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (London, England) 370:1453–1457CrossRef von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (London, England) 370:1453–1457CrossRef
13.
Zurück zum Zitat Reite A, Soreide K, Ellingsen CL et al (2015) Epidemiology of ruptured abdominal aortic aneurysms in a well-defined Norwegian population with trends in incidence, intervention rate, and mortality. J Vasc Surg 61:1168–1174CrossRefPubMed Reite A, Soreide K, Ellingsen CL et al (2015) Epidemiology of ruptured abdominal aortic aneurysms in a well-defined Norwegian population with trends in incidence, intervention rate, and mortality. J Vasc Surg 61:1168–1174CrossRefPubMed
14.
Zurück zum Zitat Sandvik OM, Soreide K, Gudlaugsson E et al (2016) Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria. Br J Surg 103:226–232CrossRefPubMed Sandvik OM, Soreide K, Gudlaugsson E et al (2016) Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria. Br J Surg 103:226–232CrossRefPubMed
15.
Zurück zum Zitat Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272CrossRef Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272CrossRef
16.
17.
Zurück zum Zitat Pohar M, Stare J (2006) Relative survival analysis in R. Comput Methods Programs Biomed 81:272–278CrossRefPubMed Pohar M, Stare J (2006) Relative survival analysis in R. Comput Methods Programs Biomed 81:272–278CrossRefPubMed
19.
Zurück zum Zitat Schmidt M, Ulrichsen SP, Pedersen L et al (2016) 30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death. Int J Cardiol 225:30–36CrossRefPubMed Schmidt M, Ulrichsen SP, Pedersen L et al (2016) 30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death. Int J Cardiol 225:30–36CrossRefPubMed
20.
Zurück zum Zitat Lasota AN, Overvad K, Eriksen HH et al (2017) Validity of peripheral arterial disease diagnoses in the Danish National Patient Registry. Eur J Vasc Endovasc Surg 53:679–685CrossRefPubMed Lasota AN, Overvad K, Eriksen HH et al (2017) Validity of peripheral arterial disease diagnoses in the Danish National Patient Registry. Eur J Vasc Endovasc Surg 53:679–685CrossRefPubMed
21.
Zurück zum Zitat Ljungman C, Adami HO, Bergqvist D et al (1991) Time trends in incidence rates of acute, non-traumatic extremity ischaemia: a population-based study during a 19-year period. Br J Surg 78:857–860CrossRefPubMed Ljungman C, Adami HO, Bergqvist D et al (1991) Time trends in incidence rates of acute, non-traumatic extremity ischaemia: a population-based study during a 19-year period. Br J Surg 78:857–860CrossRefPubMed
22.
Zurück zum Zitat Andersson T, Magnuson A, Bryngelsson IL et al (2013) All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study. Eur Heart J 34:1061–1067CrossRefPubMedPubMedCentral Andersson T, Magnuson A, Bryngelsson IL et al (2013) All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study. Eur Heart J 34:1061–1067CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Kim HK, Jung H, Cho J et al (2015) Therapeutic outcomes and thromboembolic events after treatment of acute arterial thromboembolism of the upper extremity. Ann Vasc Surg 29:303–310CrossRefPubMed Kim HK, Jung H, Cho J et al (2015) Therapeutic outcomes and thromboembolic events after treatment of acute arterial thromboembolism of the upper extremity. Ann Vasc Surg 29:303–310CrossRefPubMed
24.
Zurück zum Zitat Srebenik HH, Circulation Collateral (2002) In: Srebenik HH (ed) Concepts in anatomy. Springer, Boston, pp 201–206CrossRef Srebenik HH, Circulation Collateral (2002) In: Srebenik HH (ed) Concepts in anatomy. Springer, Boston, pp 201–206CrossRef
25.
Zurück zum Zitat Wong VW, Major MR, Higgins JP (2016) Nonoperative management of acute upper limb ischemia. Hand (New York, NY) 11:131–143CrossRef Wong VW, Major MR, Higgins JP (2016) Nonoperative management of acute upper limb ischemia. Hand (New York, NY) 11:131–143CrossRef
26.
Zurück zum Zitat Fuster V, Ryden LE, Asinger RW et al (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 22:1852–1923CrossRefPubMed Fuster V, Ryden LE, Asinger RW et al (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 22:1852–1923CrossRefPubMed
27.
Zurück zum Zitat Pisters R, Lane DA, Nieuwlaat R et al (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138:1093–1100CrossRef Pisters R, Lane DA, Nieuwlaat R et al (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138:1093–1100CrossRef
28.
Zurück zum Zitat Bruins Slot KM, Berge E (2018) Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. Cochrane Database Syst Rev 3:CD008980PubMed Bruins Slot KM, Berge E (2018) Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. Cochrane Database Syst Rev 3:CD008980PubMed
29.
Zurück zum Zitat Zirlik A, Bode C (2017) Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation. J Thromb Thrombolysis 43:365–379CrossRefPubMed Zirlik A, Bode C (2017) Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation. J Thromb Thrombolysis 43:365–379CrossRefPubMed
30.
Zurück zum Zitat Deguara J, Ali T, Modarai B et al (2005) Upper limb ischemia: 20 years experience from a single center. Vascular 13:84–91CrossRefPubMed Deguara J, Ali T, Modarai B et al (2005) Upper limb ischemia: 20 years experience from a single center. Vascular 13:84–91CrossRefPubMed
31.
32.
Zurück zum Zitat Maino A, Rosendaal FR, Algra A et al (2015) hypercoagulability is a stronger risk factor for ischaemic stroke than for myocardial infarction: a systematic review. PLoS ONE 10:e0133523CrossRefPubMedPubMedCentral Maino A, Rosendaal FR, Algra A et al (2015) hypercoagulability is a stronger risk factor for ischaemic stroke than for myocardial infarction: a systematic review. PLoS ONE 10:e0133523CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Giacalone G, Abbas MA, Corea F (2010) Prevention strategies for cardioembolic stroke: present and future perspectives. Open Neurol J 4:56–63PubMedPubMedCentral Giacalone G, Abbas MA, Corea F (2010) Prevention strategies for cardioembolic stroke: present and future perspectives. Open Neurol J 4:56–63PubMedPubMedCentral
34.
Zurück zum Zitat Hiratzka LF, Bakris GL, Beckman JA et al (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 121:e266–e369 Hiratzka LF, Bakris GL, Beckman JA et al (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 121:e266–e369
Metadaten
Titel
A Population-Based Study of Incidence, Presentation, Management and Outcome of Primary Thromboembolic Ischemia in the Upper Extremity
verfasst von
Jørgen B. Vennesland
Kjetil Søreide
Jan Terje Kvaløy
Andreas Reite
Morten Vetrhus
Publikationsdatum
13.05.2019
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 9/2019
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-019-05023-w

Weitere Artikel der Ausgabe 9/2019

World Journal of Surgery 9/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.